BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 28, 2009
View Archived Issues
EMEA grants orphan drug designation for pixantrone
Read More
EMEA recommends withdrawal of benfluorex from the market in E.U.
Read More
Sanofia-aventis withdraws MAA for Sliwens for insomnia
Read More
FDA extends PDUFA action date for Cephalon's sNDA for Nuvigil
Read More
Novartis to acquire Corthera and exclusive worldwide rights to relaxin
Read More
Shire submits BLA to the FDA for Replagal, updates Gaucher disease therapy
Read More
Encouraging phase I data reported for TRU-016 in relapsed/refractory CLL
Read More
Clinical data on pomalidomide in myelofibrosis patients disclosed at ASH meeting
Read More
Everolimus shows clinical activity in Waldenstrom's macroglobulinemia and myelofibrosis
Read More
Phase I data reported for PD-0332991 plus letrozole in advanced breast cancer
Read More
Lactobacillus rhamnosus CGMCC 1.3724 may prevent atopic dermatitis onset
Read More
Roche discloses CPT-2 inhibitors for the treatment of type 2 diabetes
Read More
Takeda describes tachykinin antagonists for IBS therapy
Read More
Wellstat Therapeutics developing URAT1 inhibitors for the treatment of gout
Read More
Vitae Pharmaceuticals and Boehringer Ingelheim claim novel antiobesity agents
Read More
GlaxoSmithKline presents S1P1 receptor agonists as antiarthritic agents
Read More
Arena submits NDA to FDA for lorcaserin for weight management
Read More
Biovitrum sells leptin modulator program to AstraZeneca
Read More
ImmuneRegen reports efficacy for its new adjuvant of a preventive cancer vaccine
Read More
Ligand obtains positive regulatory opinion in Europe for Revolade
Read More
Mylan receives tentative FDA approval for efavirenz tablets
Read More
PolyMedix completes main portions of phase Ib PMX-30063 study
Read More
Resverlogix initiates phase II atherosclerosis clinical trial
Read More
Merck to discontinue development of MK-1903 under atherosclerosis program with Arena
Read More
Synta initiates phase II study of STA-9090 in metastatic or unresectable GIST
Read More